Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

NSC 366140

Known as: NSC-366140 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
PD115934 (NSC 366140) is a soluble pyrazoloacridine derivative presently undergoing preclinical toxicology evaluation with the… Expand
  • figure 1
  • table 1
  • table 3
  • table 2
  • table 6
2004
2004
Pyrazoloacridine (PZA) is an experimental antitumor agent presently under investigation for treatment of solid tumors on the… Expand
  • figure 1
  • figure 2
  • table 1
  • table 2
  • table 3
2004
2004
AbstractBackground: Pyrazoloacridine (PZA) is thefirst of a new class of rationallysynthesized acridine derivatives to… Expand
  • figure 1
Highly Cited
1998
Highly Cited
1998
Pyrazoloacridine (PA), an acridine congener with an unknown mechanism of action, has shown selective activity against solid tumor… Expand
  • figure I
  • figure 2
  • figure 3
  • figure 4
1997
1997
Pyrazoloacridine (PA), an acridine congener that has shown selective toxicity in solid tumor cells, full activity against… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
1996
1996
Purpose. Pyrazoloacridine (PZA) is a newly developed anticancer agent currently undergoing clinical trials. Its mode of action… Expand
  • figure 2
  • figure 3
  • figure 4
  • table 1
1995
1995
Pharmacokinetic studies that consisted of measuring the plasma drug profile, tissue drug distribution, and elimination in urine… Expand
  • figure 1
  • figure 2
  • figure 3
  • table 2
  • table 3
Highly Cited
1994
Highly Cited
1994
BACKGROUND 9-Methoxypyrazoloacridine (PZA) is an anticancer agent that shows selectivity of action for carcinomas over leukemias… Expand
Highly Cited
1990
Highly Cited
1990
PD115934 (NSC 366140) is a soluble pyrazoloacridine derivative presently undergoing preclinical toxicology evaluation with the… Expand
Highly Cited
1989
Highly Cited
1989
  • R. Jackson
  • Advances in enzyme regulation
  • 1989
  • Corpus ID: 20436355
1. Antimetabolites and inhibitors of DNA topoisomerase II are relatively ineffective against quiescent cells. 2. Alkylating… Expand